How much is Expansion Therapeutics worth in 2026?

Expansion Therapeutics has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has Expansion Therapeutics raised?

Expansion Therapeutics has raised N/A in total funding across 1 funding rounds.

Expansion Therapeutics

Drug Discovery

Expansion Therapeutics valuation and funding history | Last updated: September 29, 2021 | 1 funding rounds

Current Valuation

N/A

As of September 29, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series B)

$80.0M

Last Funding

Sep 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 29, 2021	Later Stage VC (Series B)	$80.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Expansion Therapeutics is currently valued at N/A as of September 29, 2021.

Track Expansion Therapeutics Valuation Updates

Get notified when Expansion Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Expansion Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Expansion Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Expansion Therapeutics Worth in 2026?

Expansion Therapeutics is a leading private company in the Drug Discovery sector. Track Expansion Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Expansion Therapeutics Valuation is Determined

Private company valuations like Expansion Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.